findmyKOL
Clinical trialNCT04156191CompletedPhase 1Interventional

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

SponsorArcutis Biotherapeutics, Inc.Enrollment101Atopic Dermatitis (Eczema)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arcutis Clinical Site 07

    Birmingham, Alabama, United States

  • Arcutis Clinical Site 11

    Rancho Santa Margarita, California, United States

  • Arcutis Clinical Site 02

    Coral Gables, Florida, United States

  • Arcutis Clinical Site 05

    Hialeah, Florida, United States

  • Arcutis Clinical Site 13

    Miami, Florida, United States

  • Arcutis Clinical Site 01

    Mt. Pleasant, South Carolina, United States

  • Arcutis Clinical Site 06

    San Antonio, Texas, United States

  • Arcutis Clinical Site 03

    Orem, Utah, United States

  • Arcutis Clinical Site 10

    West Jordan, Utah, United States

  • Arcutis Clinical Site 12

    Spokane, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Dec 2019
Primary completion
2 May 2023
Completion
2 May 2023
Last update posted
24 Jul 2023
Registered enrollment
101
Registry id
NCT04156191

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.